Prescribed fewer benzos for children; Teva Responsible for Opioid Crisis; Food addiction?

New use of stimulants and anxiolytic / sedative-hypnotics in Canadian children has suffered a significant slump during the COVID-19 pandemic. On the flip side, the new use of antidepressants in children rose by the end of 2020 – and exceeded pre-pandemic levels. (JAMA Pediatrics)

Depression was associated with an increased risk of developing atrial fibrillation in a South Korean cohort of over 5 million adults. (JAMA network open)

A New York State jury held Teva Pharmaceuticals responsible for its involvement in the opioid crisis. (The New York Times)

In similar news, could virtual opioid use disorder treatment restrictions and regulations be hindering care soon? (NPR)

Over in England the number of hospitalizations for child eating disorders has soared over the past year that the NHS is no longer able to handle every case. (The guard)

Is the Obesity Epidemic Really Just a Food Addiction? (The hill)

Mental health platform Total Brain announced that it will license its research data from the International Study Predicting Optimized Treatment for Depression (iSPOT-D) to Alto Neuroscience for use in the development of its depression products.

The University of North Carolina received a $ 3.9 million 5-year scholarship to study the effects of estradiol on reward circuit function in a transdiagnostic sample of women with perimenopausal anhedonia and psychosis.

  • Kristen Monaco is a staff writer specializing in endocrinology, psychiatry, and nephrology. She has been with the company from her New York City office since 2015.

Comments are closed.